Top 5 Articles From the Print Publication in 2023
Articles about upcoming approvals and Humira biosimilars were among those that garnered the most interest.
Articles about upcoming approvals and Humira biosimilars were among those that garnered the most interest.
Here are the five articles published in the print publication of Managed Healthcare Executive that had the most pageviews when they were posted on the MHE website.
4 Important Approvals Expected This Year
The approval of Mounjaro (tirzepatide) for weight loss could be a tipping point for weight-loss drugs. [The weight-loss version of tirzepatide is being sold under the brand-name Zepbound.]
’Tis the Year of the Humira Biosimilars
As many as 10 Humira biosimilars [it wound up being just 8] may be on the U.S. market before 2023 is over. AbbVie has taken several steps to protect its revenues, including the launches of Skyrizi and Rinvoq.
The List of PBM Formulary Exclusions Got Longer in 2023
Pharmacy benefit managers say they exclude high-cost drugs and have alternatives on their formularies. Critics say exclusions narrow patient options and may put effective medication financially out of reach.
Why States Are Allowing Pharmacies to Dispense Returned Oncology Drugs
Repositories of donated drugs in 13 states are redistributing oncology medications to those in need.
Antibody-Drug Conjugates Find and Kill Cancer Cells
Three ADCs are in late-stage trials as treatments for patients with non-small cell lung cancer.
Healthcare Leaders Warn GOP Plan Would Deeply Chip Away At Medicaid Access
May 12th 2025Their concerns come in response to the bill unveiled Sunday night by House Republicans that would tighten eligibility rules, create work requirements and freeze provider taxes under Medicaid—the federal-state program that insures nearly 80 million low-income Americans.
Read More
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
Lack of Social Support Top Barrier to Cell and Gene Therapy Access, Survey Finds
May 12th 2025Healthcare providers are exploring ways to reduce patient travel through a growing trend of expanding sites of administration beyond academic medical centers into community and outpatient settings closer to patients' homes.
Read More
Survey Reveals Cancer Doctors Struggle to Keep Up as Treatments Advance Quickly
May 11th 2025A new survey by Johnson & Johnson revealed that oncologists are overwhelmed by the rapid pace of innovation in cancer care, with many calling for better tools, education and collaboration to help integrate new treatments and technologies into everyday practice.
Read More
